SDG demonstrated similar effects on cell growth, cytotoxicity, and cell cycle arrest when 29 compared with its metabolite enterolactone. However, the reliable stability and undetectable 30 intracellular SDG in treated cells may suggest that a metabolism of SDG, if exposed directly to 31
Introduction 36
Potential cancer prevention by dietary lignan glycoside, i.e., secoisolariciresinol 37 diglucoside (SDG), has been suggested to be mediated through its metabolites, enterolactone and 38 enterodiol [1] [2] [3] [4] [5] . The chemical structures of SDG and its mammalian metabolite enterolactone 39 are shown in Figure 1 . Enterolactone and enterodiol are anaerobically formed via colonic 40 bacterial fermentation [6] [7] . Besides the bacterial fermentation, enterolactone and enterodiol can 41 also be formed by other cell organelles such as a study that showed liver microsomes could 42 generate lignan aglycones [8] . 43 Many studies show that SDG has cancer preventive properties in animal models. Our 44 previous study demonstrated that SDG levels in wheat bran from various wheat cultivars were 45 correlated to antitumor activities in APC-Min mice [9] . We also found that dietary SDG at 46 0.01% significantly reduced azoxymethane-induced formation of aberrant crypt foci in F344 rats 47 [10] . In addition, we have shown that enterolactone and enterodiol or both in combinations 48 inhibit human cancer cell growth through inducing S-phase cell cycle arrest and apoptosis [9] . 49
Experimental animal studies by others show that dietary supplementation with 73-293 µmol/kg 50 SDG inhibits experimental metastasis of B16BL6 murine melanoma cells in C57BL/6 mice [11] . 51 However, no in vitro studies have been done to specify cancer preventive property of SDG, 52 although SDG metabolites, enterolactone and enterodiol, have been intensively investigated [12-53 18] . Therefore, we hypothesized that the dietary SDG might have a different impact from its 54 metabolites in human colonic SW480 cancer cells. 55
The objective in this study is to determine the cancer preventive effects of SDG in human 56 colon cancer SW480 cells. The effects of SDG on cellular growth and the underlying 57 mechanisms regarding cytotoxicity and cell cycle interruption were studied and compared with 58
Page 5 of 23 its metabolite enterolactone. SDG was also investigated for stability in the media when compared 59 to enterolactone. Furthermore, HPLC-MS/ESI was used to evaluate whether SDG were taken up 60 intracellularly into the cells, which may provide insight into its bioavailability and cancer 61 preventive impact. 62
Methods and materials 63

Cell culture and treatments 64
The human colon cancer SW480 cells were purchased from the American Type Culture 65
Collection (Rockville, MD), and cultured in the Dulbecco's Modified Eagle Media supplemented 66 with 10% fetal bovine serum and 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis MO). 67
The cells were cultured in either 6-well plates or 200 mL volumetric flasks at 37 0 C in 5% CO 2 68 until 60-80% confluence. At this confluence, cells were treated with either SDG or enterolactone 69 at 0-40 µM up to 48 hrs, at which the cells had reached less than 100% confluence. SDG was 70 purchased from ChromaDex (Irvine, CA), while enterolactone was purchased from either Sigma-71 Aldrich (St Louis, Mo) or ChromaDex. SDG or enterolactone was dissolved in DMSO and then 72 mixed with fresh media to achieve the final concentrations. DMSO was kept less than 0.2% in 73 the final treatment, which did not alter cell growth or cell cycle measurements when compared 74 with DMSO-free media (data not shown). After treatment, the cells were detached and counted 75 by hemacytometer as described by our previous publication [9] . 76
Cytotoxicity assay 77
The cell viability was measured in the adherent cells by trypan blue staining [9] . The 78 viable cell numbers in the treated cells were compared with that in the vehicle controls. 79
Cell cycle analysis 80
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The cell cycle analysis was done as previously described [9] [10] . Briefly, the cells were 81 fixed in ethanol, centrifuged and then the pellet was resuspended in the phosphate buffer saline 82 solution at pH 7.4, containing 20 g/L propidium iodide and 5000 U/L of RNase (Promega) at 37 83 o C for 30 min. DNA flow cytometric analysis (FACSCaliber, Becton Dickinson, Newyork, NJ) 84 was performed with an excitation at 488 nm and an emission at 630 nm. 85
Western blot analysis for cyclin A protein 86
As described in our previous publication [9] , the treated cells were harvested and 87 suspended in Triton lysis buffer. 
HPLC-MS/ESI analysis of intracellular levels of SDG and enterolactone 114
The SW480 cells treated with 40 µM SDG or enterolactone for 48 hr were harvested by 115 detaching with trypsin-EDTA as previously described [9] and centrifuged at 1000 X g for 10 116
min. The supernatant was discarded and the pellet was washed by three times and resuspended in 117 means ± SEM and a probability at < 0.05 is considered significantly. 137
Results 138
Cell growth inhibition 139
As shown in Figure 2 , treatment of SW480 cells with either SDG or enterolactone at 0-40 140 µM up to 48 hrs resulted in a dose-and time-dependent decrease in cell number when compared 141 with the vehicle control. 142
Cytotoxicity Assay 143
The cell viability was generally greater than 80% in the adherent cells, and the treated 144 cells did not differ significantly from the vehicle-treated controls (data not shown). 145
Cell cycle Analysis 146
The treatment of SW480 cells with either SDG or enterolactone at 30-40 μM for either 24 147 or 48 hrs induced cell cycle arrest at S-phase significantly ( Figure 3) . As the percentage of cellsin S-phase increased, the percentage of cells at both G1 and G2/M phases decreased 149 correspondingly. 150
Cyclin A protein levels 151
The levels of cyclin A protein significantly increased in the cells treated with SDG at 20-152 40 μM or enterolactone at 40 μM for 48 hrs when compared to the vehicle control (Figure 4) . 153
Stability of SDG vs. enterolactone in the medium 154
The concentrations of SDG and enterolactone in the cell culture media after treatment 155
were measured over the time by HPLC method. Figure 5A showed a representative HPLC 156 chromatograph of the standard SDG with two common SDG metabolites, i.e., enterodiol and 157 enterolactone. The retention times of SDG, enterodiol, and enterolactone are 20.5, 25.4, and 28.6 158 min, respectively. By using this established HPLC method, either enterolactone or SDG was 159 detectable in the media after treatment as shown in Figure 5B and 5C, respectively. 160
The stability of SDG and enterolactone in the media with or without SW480 cells for 48 161 hr was further evaluated. As shown in Figure 6 , SDG generally exhibited greater stability than 162 enterolactone in the media with or without the cells. About 95% of SDG at 40 µM in the media 163 without the cells was detectable after 48 hr treatment verse 57% of enterolactone only. Both 164 SDG and enterolactone at 10-40 µM resulted in the greater losses in the presence of SW480 165 cells, likely due to uptake and/or degradation by cellular enzymes. 166
Intracellular levels of SDG verse enterolactone 167
In comparison with the representative HPLC chromatograph of SDG, enterodiol, 168 enterolactone, and internal standard flavone ( Figure 7A ), a HPLC chromatograph in Figure 7B concentrations up to 40 μM tested in this study was also supported. 196 In this study, we demonstrate that SDG inhibits colon cancer cell growth by inducing S-197 phase cell cycle arrest, a characteristic previously attributable mostly to its metabolites. In 198 addition, not only does SDG inhibit colon cancer growth but it is also much more stable than 199 enterolactone in the cell culture media. 200
When we reject our hypothesis that SDG might provide different effect on cancer cell 201 growth when compared with its metabolite entrolantone, we found the effects of SDG and 202 enterolactone on the cell growth, cell viability, and cell cycle arrest are comparable. However, a 203 higher stability of SDG in the media than enterolactone may be related to the nature of chemical 204 structure and the chemical groups attached. The bulky glucose moieties in the SDG structure 205 may prevent attack from the possible electrophiles in the cell culture media. In addition, the 206 presence of two methoxy groups attached to outer carbon benzene rings in the SDG structure 207 may allow for an increased electron delocalization, and hence could be more stable in the 208 inherent SDG structure [21] . This notion is consistent with the observation that SDG was stable 209 in the bread products during baking [22] . On the other hand, the reactive lactone group on 210 enterolactone tends to be unstable as reported in antibacterial studies by using lactone functional 211 groups [23, 24] . In addition, the accessibility of enterolactone functional groups to the potential 212 electrophiles appears high. Although, ChemDraw ultra software predicts a negative overall 213 enthalpy on the enterolactone structure [25] , the lactone functional group and the openness of the 214 enterolactone structure may tend to overshadow this effect towards increased enterolactone 215
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It is a challenge to detect intracellular levels of a phytochemical such as lignans. Based 217 upon our previous experience in flavonoid apigenin [26] and lignan analysis [9] [10] 27] those potential metabolites in this moment. Although SDG and/or its metabolites were not 225 detectable in the treated cells, it should be noted that it was not expected for intact SDG to be 226 absorbed, since a phytochemical glycoside is usually deglycosilation by β-glucosidase or lactase 227 phlorozin hydrolase [28] . Therefore, SDG-treated cells with undetectable intracellular SDG or its 228 currently known metabolites observed in this study may provide novel insight into SDG 229 metabolism and bioavailability if exposed directly to the colonic cells before degradation by 230 microorganisms in human gut. 231
In conclusion, SDG displayed significant anticancer effects as indicated by the inhibition 232 of colon cancer cell growth. This effect was associated partly with the induction of cell cycle 233 arrest at S-phase. Also, the stability of SDG is much higher in the cell culture media than 234 enterolactone. Intracellular level studies revealed that enterolactone taken up by enterolactone-235 treated cells, but not SDG as it was undetectable in SDG-treated cells. The reliable stability and 236 undetectable intracellular SDG in treated cells may suggest a metabolism of SDG, if exposed 237 directly to the colonic cells, could be different from the currently known degradation by 238 microorganisms in human gut. 
